HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibition of GTP cyclohydrolase reduces cancer pain in mice and enhances analgesic effects of morphine.

Abstract
Noncoding polymorphisms of the GTP cyclohydrolase gene (GCH1) reduce the risk for chronic pain in humans suggesting GCH1 inhibitors as analgesics. We assessed the effects of the GCH1 inhibitor diaminohydroxypyrimidine (DAHP) on nociception and inflammation in a mouse melanoma and a sarcoma cancer pain model, and its co-effects with morphine in terms of analgesic efficacy and respiratory depression. GCH1 inhibition did not reduce the tumor-evoked nociceptive hypersensitivity of the tumor-bearing paw. However, DAHP reduced melanoma- and sarcoma-evoked systemic hyperalgesia as determined by analyzing contralateral paws. GCH1 inhibition increased the inflammatory edema and infiltration with polymorphonuclear leukocytes surrounding the tumor but reduced the tumor-evoked microglia activation in the spinal cord suggesting that an increase of the local immune attack against the tumor may avoid general pain hypersensitivity. When used in combination with morphine at high or low doses, GCH1 inhibition increased and prolonged the analgesic effects of the opioid. It did not, however, increase the respiratory depression caused by morphine. Conversely, the GCH1-product, tetrahydrobiopterin, caused hyperalgesia, antagonized antinociceptive effects of morphine, and aggravated morphine-evoked respiratory depression, the latter mimicked by a cGMP analog suggesting that respiratory effects were partly mediated through the BH4-NO-cGMP pathway. The observed effects of GCH1 inhibition in the tumor model and its enhancement of morphine-evoked antinociception without increase of morphine toxicity suggest that GCH1 inhibitors might be useful as co-therapeutics for opioids in cancer patients.
AuthorsGeethanjali Pickert, Thekla Myrczek, Steven Rückert, Andreas Weigert, Annett Häussler, Nerea Ferreirós, Bernhard Brüne, Jörn Lötsch, Irmgard Tegeder
JournalJournal of molecular medicine (Berlin, Germany) (J Mol Med (Berl)) Vol. 90 Issue 12 Pg. 1473-86 (Dec 2012) ISSN: 1432-1440 [Electronic] Germany
PMID22706600 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • 5-dehydro-3-deoxy-D-arabino-heptulosonic acid-7-phosphate
  • Sugar Acids
  • Morphine
  • GTP Cyclohydrolase
Topics
  • Animals
  • GTP Cyclohydrolase (antagonists & inhibitors, metabolism)
  • Male
  • Melanoma (drug therapy, enzymology)
  • Mice
  • Mice, Inbred C57BL
  • Morphine (therapeutic use)
  • Neoplasms (drug therapy, enzymology)
  • Pain (drug therapy, enzymology)
  • Sarcoma (drug therapy, enzymology)
  • Sugar Acids (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: